Targeted therapeutics based on engineered proteins that bind EGFR

Details for Australian Patent Application No. 2009213141 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Morse, Brent; Camphausen, Ray; Fabrizio, David; Emanuel, Stuart

Agent A J Park

Pub. Number AU-A-2009213141

PCT Pub. Number WO2009/102421

Priority 61/065,955 14.02.08 US

Filing date 10 February 2009

Wipo publication date 20 August 2009

International Classifications

C07K 14/78 (2006.01) Peptides having more than 20 amino acids

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/102421 Priority application(s): WO2009/102421

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009213147-Modified RNAi polynucleotides and uses thereof

2009213140-Integrated device for analyte testing, confirmation, and donor identity verification